10:24 AM EST - Tilray Brands Inc. : Says its Tilray Medical branch considers the recent guidance issued by the National Association of Statutory Health Insurance Physicians (KBV) and the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) on the prescription of medical cannabis in the form of standardized full-spectrum extracts a step in the right direction. Tilray Brands Inc.
shares T.TLRY are trading up $0.02 at $6.23.
